- Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
- Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
- Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
- Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
- Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
- Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
- Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
More ▼
Key statistics
On Wednesday, Biodesix Inc (BDSX:NMQ) closed at 1.25, 21.36% above the 52 week low of 1.03 set on Jul 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.23 |
---|---|
High | 1.25 |
Low | 1.23 |
Bid | 1.07 |
Offer | 1.62 |
Previous close | 1.25 |
Average volume | 29.85k |
---|---|
Shares outstanding | 113.63m |
Free float | 42.58m |
P/E (TTM) | -- |
Market cap | 142.03m USD |
EPS (TTM) | -0.6469 USD |
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼